Get the Stockscreener App
64.62
1.24%
0.80
Centene Corp stock is traded at $64.62, with a volume of 2.77M.
It is up +1.24% in the last 24 hours and down -10.36% over the past month.
Centene is a managed care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of September, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare Advantage (about 5%). The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program and has a military contract.
See More
Previous Close:
$63.82
Open:
$63.48
24h Volume:
2.77M
Relative Volume:
0.62
Market Cap:
$32.14B
Revenue:
$157.75B
Net Income/Loss:
$2.82B
P/E Ratio:
14.52
EPS:
4.45
Net Cash Flow:
$2.26B
1W Performance:
+6.58%
1M Performance:
-10.36%
6M Performance:
-13.63%
1Y Performance:
-6.79%
1-Day Range:
$62.93
$64.64
1-Week Range:
$60.49
$65.40
52-Week Range:
$59.77
$81.42
Centene Corp Stock (CNC) Company Profile
Name
Centene Corp
Sector
Industry
Phone
(314) 725-4477
Address
7700 FORSYTH BLVD., ST LOUIS
Centene Corp Stock (CNC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-05-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-30-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-20-23 | Initiated | UBS | Neutral |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-08-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-23-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-13-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-30-22 | Initiated | Argus | Buy |
| Aug-26-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-28-22 | Resumed | Barclays | Overweight |
| Jul-14-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-21-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Resumed | Bernstein | Outperform |
| May-26-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-07-22 | Resumed | Barclays | Overweight |
| Jan-06-22 | Resumed | JP Morgan | Overweight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Dec-13-21 | Reiterated | BMO Capital Markets | Outperform |
| Dec-13-21 | Reiterated | BofA Securities | Buy |
| Dec-13-21 | Reiterated | Credit Suisse | Neutral |
| Dec-13-21 | Reiterated | Mizuho | Neutral |
| Dec-13-21 | Reiterated | Oppenheimer | Outperform |
| Dec-13-21 | Reiterated | Stephens | Overweight |
| Dec-13-21 | Reiterated | Truist | Buy |
| Dec-13-21 | Reiterated | Wells Fargo | Overweight |
| Dec-13-21 | Reiterated | Wolfe Research | Outperform |
| Nov-01-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Jul-09-21 | Initiated | Seaport Global Securities | Buy |
| May-19-21 | Initiated | Wells Fargo | Overweight |
| May-11-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-10-21 | Initiated | Mizuho | Neutral |
| Jan-21-21 | Resumed | Goldman | Neutral |
| Jan-15-21 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Feb-05-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-03-20 | Resumed | Evercore ISI | Outperform |
| Jan-28-20 | Reiterated | Bernstein | Outperform |
| Jan-06-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| May-10-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Oct-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Jul-18-18 | Resumed | Citigroup | Neutral |
| Dec-18-17 | Reiterated | Jefferies | Buy |
| Sep-13-17 | Reiterated | Leerink Partners | Mkt Perform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-22-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
| Mar-23-17 | Downgrade | Citigroup | Buy → Neutral |
| Feb-08-17 | Reiterated | Barclays | Overweight |
| Feb-07-17 | Resumed | Cantor Fitzgerald | Overweight |
| Jan-04-17 | Initiated | Piper Jaffray | Overweight |
View All
Centene Corp Stock (CNC) Latest News
Centene Co. (NYSE:CNC) Stock Holdings Lessened by New York State Common Retirement Fund - MarketBeat
Centene (NYSE:CNC) Given New $90.00 Price Target at Wells Fargo & Company - MarketBeat
Centene Co. (NYSE:CNC) Shares Bought by Wealth Enhancement Advisory Services LLC - MarketBeat
Centene Corp. stock outperforms competitors on strong trading day - MarketWatch
CENTENE SUBSIDIARY BUCKEYE HEALTH PLAN AWARDED CONTRACT TO SERVE DUAL ELIGIBILE MEDICARE AND MEDICAID MEMBERS IN OHIO - Yahoo Finance
US Bancorp DE Raises Stock Holdings in Centene Co. (NYSE:CNC) - MarketBeat
Centene sues feds over Medicare Advantage score - The Business Journals
New York State Teachers Retirement System Decreases Stake in Centene Co. (NYSE:CNC) - MarketBeat
AcariaHealth Shines at the 2024 NASP Annual Meeting: Transforming Specialty Pharmacy - Yahoo Finance
Centene Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
CENTENE NAMED ONE OF FORTUNE'S® 100 BEST LARGE WORKPLACES FOR WOMEN™ 2024 - Quantisnow
WHAT THEY ARE SAYING: 'Significant Positive Impact to…Patients,' Independent Physicians Say About $2 Million in Grants from Health Net - Quantisnow
Centene (NYSE:CNC) Price Target Cut to $91.00 by Analysts at Barclays - MarketBeat
DekaBank Deutsche Girozentrale Sells 46,842 Shares of Centene Co. (NYSE:CNC) - MarketBeat
Centene (NYSE:CNC) Lowered to "Buy" at StockNews.com - MarketBeat
Is Centene Corporation (CNC) the Most Profitable Value Stock To Invest In? - Insider Monkey
Centene stock faces target cut with 2025 rate request and margin outlook in focus - Investing.com
Centene's SWOT analysis: managed care giant faces medicaid challenges - Investing.com
Centene (NYSE:CNC) Stock Price Down 3.1% Following Analyst Downgrade - MarketBeat
Forsta AP Fonden Buys 13,900 Shares of Centene Co. (NYSE:CNC) - MarketBeat
Centene Corporation (NYSE:CNC) Q3 2024 Earnings Call Transcript - Insider Monkey
Centene Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Centene beats investor expectations despite Medicaid headwinds - Yahoo Finance
Centene Corp (CNC) Q3 2024 Earnings Call Highlights: Strong EPS and Strategic Medicaid Growth - GuruFocus.com
Decoding Centene Corp (CNC): A Strategic SWOT Insight - Yahoo Finance
Centene: Q3 Earnings Snapshot - mySA
Centene Stock Rises 29% in a Year: Evaluating the Road Ahead - MSN
Centene, HCA, Universal: Healthcare earnings in focus - Yahoo Finance
Centene Q3 Earnings Beat On Growth In Marketplace Business Line - Barchart
Centene posts Q3 profit, beats Wall Street estimates - The Business Journals
Centene Q3 Earnings Beat on Growth in Marketplace Business Line - Yahoo Finance
Centene Faces Near-Term Rate and Utilization Headwinds in Medicaid Market - Morningstar
Centene’s stock soars 11% after earnings sweep past estimates - MSN
Centene reports $713 million profit - Business Insurance
Centene (NYSE:CNC) Shares Gap UpStill a Buy? - MarketBeat
Top Stock Movers Now: Tapestry, Centene, HCA Healthcare, and More - Yahoo Finance
Centene Stock Pops on Membership Growth, Premium and Service Sales - Yahoo Finance
Centene’s stock soars after earnings crush estimates, company backs guidance - MarketWatch
Health insurer Centene eases investor fears with better-than-expected profit - Reuters
Colgate-Palmolive, Centene, Microsoft: 3 stocks in focus - Yahoo Finance
Centene (CNC) Profit Beats Estimates on Boost From Lower Taxes - Bloomberg
Centene (CNC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Centene’s stock soars 14% after earnings sweep past estimates and company backs guidance - MSN
Centene shares surge as Q3 profits outperform expectations - Modern Healthcare
Earnings Summary: Everything you need to know about Centene’s Q3 report - AlphaStreet
Centene Says It Is Positioned To Capture Long-Term Growth In Government-Sponsored Healthcare, Lifts Annual Outlook - Yahoo Finance
Centene Corp Stock Jumps Pre-Market As Q3 Results Top Estimates: Retail Goes ‘Extremely Bullish’ - Barchart
S&P 500 Futures Rise in Premarket Trading; Tapestry, Deckers Outdoor Lead - Barron's
Centene jumps after massive Q3 beat and guidance raise - MSN
Centene Corp (CNC) Q3 2024 Earnings: EPS of $1.36, Revenue Hits $42.0 Billion, Surpassing Estimates - GuruFocus.com
Centene jumps after massive Q3 beat and guidance raise (CNC:NYSE) - Seeking Alpha
Centene Corp Stock (CNC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.85%
6.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):